Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-049974
Filing Date
2015-08-14
Accepted
2015-08-14 17:15:55
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v417775_10q.htm 10-Q 479825
2 EXHIBIT 31.1 v417775_ex31-1.htm EX-31.1 8349
3 EXHIBIT 31.2 v417775_ex31-2.htm EX-31.2 8443
4 EXHIBIT 32.1 v417775_ex32-1.htm EX-32.1 4651
5 EXHIBIT 32.2 v417775_ex32-2.htm EX-32.2 5067
  Complete submission text file 0001144204-15-049974.txt   5025185

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imnp-20150630.xml EX-101.INS 1018309
7 XBRL TAXONOMY EXTENSION SCHEMA imnp-20150630.xsd EX-101.SCH 53639
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20150630_cal.xml EX-101.CAL 47121
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20150630_def.xml EX-101.DEF 381144
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20150630_lab.xml EX-101.LAB 403772
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20150630_pre.xml EX-101.PRE 414470
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36602 | Film No.: 151057090
SIC: 2834 Pharmaceutical Preparations